| Soluble urokinase receptor (SuPAR) in COVID-19–related AKI TU Azam, HR Shadid, P Blakely, P O’Hayer, H Berlin, M Pan, P Zhao, ... Journal of the American Society of Nephrology 31 (11), 2725-2735, 2020 | 136 | 2020 |
| Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department MA Stauning, I Altintas, T Kallemose, J Eugen-Olsen, MB Lindstrøm, ... The Journal of emergency medicine 61 (3), 298-313, 2021 | 24 | 2021 |
| suPAR cut-offs for risk stratification in patients with symptoms of COVID-19 I Altintas, J Eugen-Olsen, S Seppälä, J Tingleff, MA Stauning, NO El Caidi, ... Biomarker Insights 16, 11772719211034685, 2021 | 22 | 2021 |
| First reported human bloodstream infection with Vagococcus lutrae I Altintas, V Andrews, MV Larsen New Microbes and New Infections 34, 100649, 2020 | 16 | 2020 |
| Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19 S Luo, A Vasbinder, JM Du‐Fay‐de‐Lavallaz, JMD Gomez, T Suboc, ... Journal of the American Heart Association 11 (18), e025198, 2022 | 12 | 2022 |
| Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19-a prospective cohort study J Eugen-Olsen, I Altintas, J Tingleff, M Stauning, H Gamst-Jensen, ... medRxiv, 2020.05. 27.20114678, 2020 | 6 | 2020 |
| Development and validation of prognostic machine learning models for short-and long-term mortality among acutely admitted patients based on blood tests BN Jawad, SM Shaker, I Altintas, J Eugen-Olsen, JO Nehlin, O Andersen, ... Scientific Reports 14 (1), 5942, 2024 | 4 | 2024 |
| Biomarkers and the post-thrombotic syndrome: A systematic review of biomarkers associated with the occurrence of the post-thrombotic syndrome after lower extremity deep venous … AN Harbsmeier, I Altintas, K Iversen, O Andersen, JO Nehlin Phlebology 38 (9), 577-598, 2023 | 3 | 2023 |
| Appetite stimulation with cannabis‐based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocol RL Nielsen, O Bornaes, IK Storgaard, T Kallemose, LM Jørgensen, ... Basic & clinical pharmacology & toxicology 133 (3), 237-253, 2023 | 2 | 2023 |
| Development and validation of prognostic machine learning models for short-and long-term mortality among acutely hospitalized patients. BJ Jawad, SM Shaker, I Altintas, J Eugen-Olsen, J Nehlin, O Andersen, ... | 1 | 2023 |
| The Predictive Role of C-Reactive Protein, Leukocyte Cell Count, and Soluble Urokinase Plasminogen Activator Receptor for Pulmonary Sequelae in Hospitalized COVID-19 Survivors … I Altintas, T Kallemose, MB Lindstrøm, I Parvaiz, I Rokkedal, ... | | 2024 |
| Role of immunosenescence in impaired wound healing with age I Altintas, O Andersen, JO Nehlin Academic Press, 2024 | | 2024 |
| Prospective and External Validation of Prognostic Machine Learning Models for Short-and Long-Term Mortality Among Acutely Admitted Patients Based on Blood Tests BN Jawad, I Altintas, J Eugen-Olsen, S Niazi, A Mansouri, ... Available at SSRN 4787471, 2024 | | 2024 |
| Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19-a prospective cohort study I Altintas, J Tingleff, M Stauning, H Gamst-Jensen, MB Lindstroem, ... | | 2020 |
| Deep vein thrombosis of upper extremity in a young man I Altintas | | 2019 |
